[1]
2024. Prospective Study on Low-Dose Mifepristone for the Treatment of Leiomyoma: A Hospital Based Study. International Archives of BioMedical and Clinical Research. 4, 1 (Apr. 2024), 104–106. DOI:https://doi.org/10.21276/6jye9820.